Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 317006011000036113 | lidocaine hydrochloride 1.5% (300 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, 5 x 20 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 317009011000036116 | epinephrine 100 microgram / 20 mL + lidocaine hydrochloride 300 mg / 20 mL injection, 5 x 20 mL vials (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| lidocaine hydrochloride 1.5% (300 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, 5 x 20 mL vials | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| lidocaine hydrochloride 1.5% (300 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, 5 x 20 mL vials | has MPUU | lidocaine hydrochloride 1.5% (300 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Xylocaine 1.5% with Adrenaline 1 in 200 000 injection, 5 x 20 mL vials | Is a | True | lidocaine hydrochloride 1.5% (300 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, 5 x 20 mL vials | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR